194 related articles for article (PubMed ID: 31677197)
21. Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient.
Russo G; Isobe M; Gatti R; Finan J; Batuman O; Huebner K; Nowell PC; Croce CM
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):602-6. PubMed ID: 2783489
[TBL] [Abstract][Full Text] [Related]
22. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire.
Garand R; Goasguen J; Brizard A; Buisine J; Charpentier A; Claisse JF; Duchayne E; Lagrange M; Segonds C; Troussard X; Flandrin G
Br J Haematol; 1998 Nov; 103(2):488-94. PubMed ID: 9827924
[TBL] [Abstract][Full Text] [Related]
23. Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia.
Mikhaylenko N; Wahnschaffe L; Herling M; Roeder I; Seifert M
PLoS One; 2022; 17(9):e0274463. PubMed ID: 36129940
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
[TBL] [Abstract][Full Text] [Related]
25. T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Gutierrez M; Bladek P; Goksu B; Murga-Zamalloa C; Bixby D; Wilcox R
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569479
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of Novel
Kanagal-Shamanna R; Bao H; Kearney H; Smoley S; Tang Z; Luthra R; Yang H; Zhang S; Lin P; Wu D; Medeiros LJ; Lu X
Leuk Lymphoma; 2022 Apr; 63(4):865-875. PubMed ID: 34898335
[No Abstract] [Full Text] [Related]
27. Next-generation amplicon TRB locus sequencing can overcome limitations of flow-cytometric Vβ expression analysis and confirms clonality in all T-cell prolymphocytic leukemia cases.
Kotrova M; Novakova M; Oberbeck S; Mayer P; Schrader A; Knecht H; Hrusak O; Herling M; Brüggemann M
Cytometry A; 2018 Nov; 93(11):1118-1124. PubMed ID: 30414304
[TBL] [Abstract][Full Text] [Related]
28. T-cell prolymphocytic leukemia with a novel translocation (6;11)(q21;q23).
Wong KF; Chan JK; Sin VC
Cancer Genet Cytogenet; 1999 Jun; 111(2):149-51. PubMed ID: 10347553
[TBL] [Abstract][Full Text] [Related]
29. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization.
Maljaei SH; Brito-Babapulle V; Hiorns LR; Catovsky D
Cancer Genet Cytogenet; 1998 Jun; 103(2):110-6. PubMed ID: 9614908
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia.
Tian S; Zhang H; Zhang P; Kalmbach M; Lee JH; Ordog T; Hampel PJ; Call TG; Witzig TE; Kay NE; Klee EW; Slager SL; Yan H; Ding W
Sci Rep; 2021 Apr; 11(1):8318. PubMed ID: 33859327
[TBL] [Abstract][Full Text] [Related]
32. Micro-RNA networks in T-cell prolymphocytic leukemia reflect T-cell activation and shape DNA damage response and survival pathways.
Braun T; Glass M; Wahnschaffe L; Otte M; Mayer P; Franitza M; Altmüller J; Hallek M; Hüttelmaier S; Schrader A; Herling M
Haematologica; 2022 Jan; 107(1):187-200. PubMed ID: 33543866
[TBL] [Abstract][Full Text] [Related]
33. Translocations t(X;14)(q28;q11) and t(Y;14)(q12;q11) in T-cell prolymphocytic leukemia.
de Oliveira FM; Tone LG; Simões BP; Rego EM; Marinato AF; Jácomo RH; Falcão RP
Int J Lab Hematol; 2009 Aug; 31(4):453-6. PubMed ID: 18294235
[TBL] [Abstract][Full Text] [Related]
34. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
Sun S; Fang W
Biomed Pharmacother; 2020 Jun; 126():110107. PubMed ID: 32247279
[TBL] [Abstract][Full Text] [Related]
35. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
[TBL] [Abstract][Full Text] [Related]
36. Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia.
Miyata A; Kojima K; Yoshino T; Fujii S; Shinagawa K; Ichimura K
Int J Hematol; 2001 Feb; 73(2):230-5. PubMed ID: 11372737
[TBL] [Abstract][Full Text] [Related]
37. A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia.
Soulier J; Pierron G; Vecchione D; Garand R; Brizard F; Sigaux F; Stern MH; Aurias A
Genes Chromosomes Cancer; 2001 Jul; 31(3):248-54. PubMed ID: 11391795
[TBL] [Abstract][Full Text] [Related]
38. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
[TBL] [Abstract][Full Text] [Related]
39. [Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation].
Momose H; Kurita N; Nishikii H; Yusa N; Yokoyama K; Shimizu E; Imoto S; Nanmoku T; Maruyama Y; Sakamoto T; Yokoyama Y; Kato T; Matsuoka R; Obara N; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2024; 65(1):35-40. PubMed ID: 38311387
[TBL] [Abstract][Full Text] [Related]
40. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.
Kiel MJ; Velusamy T; Rolland D; Sahasrabuddhe AA; Chung F; Bailey NG; Schrader A; Li B; Li JZ; Ozel AB; Betz BL; Miranda RN; Medeiros LJ; Zhao L; Herling M; Lim MS; Elenitoba-Johnson KS
Blood; 2014 Aug; 124(9):1460-72. PubMed ID: 24825865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]